Drug Profile
VRP 700
Alternative Names: VRP-700Latest Information Update: 28 Sep 2016
Price :
$50
*
At a glance
- Originator Unknown
- Developer Verona Pharma
- Class Antitussives
- Mechanism of Action Sensory receptor cell inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Cough
Highest Development Phases
- No development reported Cough
Most Recent Events
- 28 Sep 2016 VRP 700 is available for licensing as of 28 Sep 2016. http://www.veronapharma.com/joomla/index.php/products
- 18 Feb 2016 No development reported - Phase-II for Cough in United Kingdom (Inhalation)
- 25 Mar 2013 Phase-II clinical trials in Cough in United Kingdom (Inhalation)